Wave Life Sciences First Quarter 2024 Earnings: US$0.24 loss per share (vs US$0.27 loss in 1Q 2023) [Yahoo! Finance]
Wave Life Sciences Ltd. - Ordinary Shares (WVE)
Last wave life sciences ltd. - ordinary shares earnings: 3/2 06:45 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.wavelifesciences.com/news-releases?page=1%2c0%2c0%2c0
Company Research
Source: Yahoo! Finance
Net loss: US$31.6m (loss widened by 15% from 1Q 2023). US$0.24 loss per share. All figures shown in the chart above are for the trailing 12 month (TTM) period Wave Life Sciences Earnings Insights Looking ahead, revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 9.4% growth forecast for the Pharmaceuticals industry in the US. Performance of the American Pharmaceuticals industry. The company's shares are down 2.0% from a week ago. Risk Analysis It's still necessary to consider the ever-present spectre of investment risk. We've identified 3 warning signs with Wave Life Sciences , and understanding them should be part of your investment process. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbias
Show less
Read more
Impact Snapshot
Event Time:
WVE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
WVE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
WVE alerts
High impacting Wave Life Sciences Ltd. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
WVE
News
- Atalanta Therapeutics Expands Executive Team with Appointments of Chief Medical Officer and Chief Financial Officer [Yahoo! Finance]Yahoo! Finance
- Wave Life Sciences Ltd. (NASDAQ: WVE) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $11.00 price target on the stock.MarketBeat
- Wave Life Sciences Ltd. (NASDAQ:WVE) Just Reported First-Quarter Earnings And Analysts Are Lifting Their Estimates [Yahoo! Finance]Yahoo! Finance
- Wave Life Sciences Ltd. (NASDAQ: WVE) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
- Wave Life Sciences Ltd. (NASDAQ:WVE) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
WVE
Earnings
- 5/9/24 - Miss
WVE
Sec Filings
- 5/10/24 - Form 10-Q
- 5/9/24 - Form 8-K
- 4/29/24 - Form 10-K/A
- WVE's page on the SEC website